Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times Virgin Islands.
Press releases published on August 28, 2025
TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation
GlobeNewswire
·
August 28, 2025
TT125-802 is a small molecule CBP/p300 bromodomain inhibitor that shows clinical activity as single agent in solid tumors, including advanced EGFR-mutated and KRAS-G12C-mutated non-small cell lung cancer (NSCLC) 1 in 5 cancer-related deaths in the US are …
Oculis to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 28, 2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet …
Dermatology Expert Laurel Leithauser, MD, FFAD, FACMS, Offers UV Protection and Skin Cancer Screening Advice in HelloNation
GlobeNewswire
·
August 28, 2025
TRAVERSE CITY, Mich., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Why should residents in Traverse City treat a skin cancer screening like any other annual health exam? In HelloNation, Dr. Laurel Leithauser of Leithauser Skin Institute explains why routine checkups …
Veterinary Expert Dr. Ben Nemmers Explains What Most People Don’t Realize About Boarding with Vet Care in HelloNation
GlobeNewswire
·
August 28, 2025
CEDAR FALLS, Iowa, Aug. 28, 2025 (GLOBE NEWSWIRE) -- What makes pet boarding with veterinary care different from a standard kennel stay? In HelloNation, Dr. Ben Nemmers of Companion Animal Clinic …
argenx to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
August 28, 2025 Amsterdam, the Netherlands – argenx (Euronext …
Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension
GlobeNewswire
·
August 28, 2025
Allschwil, Switzerland – August 28, 2025 Idorsia Ltd (SIX: IDIA) releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – fits into the treatment landscape for …
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
August 28, 2025
- The offering was made to two new fundamental institutional investors - - The Company intends to use the net proceeds to fund preparation for our Phase 3 programs of zervimesine in neurodegenerative disorders - PURCHASE, N.Y., Aug. 27, 2025 (GLOBE …